Mercer, the large human resources consulting firm, predicts solid employment and wage growth throughout the Asian region in 2018 to 2019. One of the strongest areas for growth will be in the life sciences industry in China. Since there has been a... Read More
Many Chinese citizens today are demanding better drugs and treatments for diseases. IQVIA Holdings predicts that the China drug market will grow by 30% over the next few years, reaching $170 billion in sales. Last year, China added about 100 Western drugs... Read More
Under popular pressure to boost the affordability of cancer medications, China’s health insurance regulator announced in August that it will add a range of cancer drugs to the list of those already covered by the national medical insurance system. At the same... Read More
This article was originally published on Medtech Intelligence. Hospitals in key Asian countries are enjoying strong growth prospects, spurred by aging populations, a rising middle class, an expansion of public health insurance, and the encouragement of private and foreign investment in the... Read More
The market in India for in vitro diagnostics (IVDs)—the simple but effective laboratory tests on tissue samples used to detect diseases, conditions, and infections—is growing by a rapid 8.6% annually, according to a report from The Business Research Company. India’s IVD market... Read More
One year after Singapore launched an initiative to establish itself as a regional leader for artificial intelligence (AI) research and entrepreneurship, the city-state is well on its way to harnessing the power of intelligent computing to tackle some of its most pressing... Read More
Flush with cash and eager to gain earlier and easier access to innovative drug technologies, Chinese investors have been pumping money into Western biotech startups over the past two years. But despite this recent trend, U.S. President Donald Trump’s plan to limit... Read More
More than 450 million Chinese—one in three people in the world’s most populous country—suffer from nearsightedness, according to statistics released by China’s National Health Commission in June. Sixty years ago, 10%-20% of the Chinese population was short-sighted. Today, one third—including a startling... Read More
This article was originally published on MedTech Intelligence. More and more Chinese investment companies are putting their money into Western medtech companies these days. Just recently, Grail, Inc., a California-based early cancer detection company, secured a $300 million Series C funding round... Read More
General healthcare spending in South Korea jumped by 6.8% on average each year between 2005 and 2015, according to a report released in May by the Korea Institute for Health and Social Affairs. The spending, fueled by an aging society, a fast... Read More